Clover Health Investments, Corp (CLOV) — Analysis Summary
Clover Health Investments, Corp (CLOV) has a market cap of $2.25B with year-over-year revenue growth of +40.3%. Net margin stands at -4.4%. The stock trades at a P/E ratio of -114.4.
Key Takeaways
- Revenue changed +40.3% year-over-year
- Net margin of -4.4%
- P/E ratio of -114.4
Compared to other companies in the HOSPITAL & MEDICAL SERVICE PLANS sector, CLOV posted revenue growth of +40.3% and trades at a P/E of -114.4.
Clover Health Investments, Corp (CLOV)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
Sector
HOSPITAL & MEDICAL SERVICE PLANS
Employees
724
Headquarters
JERSEY CITY, NJ
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.